Answers are grounded in this paper and cite their sources.
Shows how elevated fetuin-A promotes insulin resistance and accelerates atherosclerosis in type-2 diabetes, highlighting its utility as a hepatic biomarker.
OBJECTIVES: Fetuin-A is a circulating glycoprotein, formed in the liver. It regulates bone remodelling and calcium metabolism. Fetuin-A has adipogenic properties, so fat accumulation in the liver may be associated with higher levels of fetuin-A. Fetuin-A is an inhibitor of the phosphorylation of the insulin receptor tyrosine kinase. KEY FINDINGS: High concentrations of fetuin-A in humans causes insulin resistance. Insulin sensitivity is also found to be increased in fetuin-A knockout mice. Fetuin-A has been shown to cause insulin resistivity in type-2 diabetes mellitus and worsens the pro-atherogenic milieu. SUMMARY: Fetuin-A should be considered as a hepatic bio-marker. Vascular diseases like atherosclerosis are major causes of disability in patients with diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: